Dinklo T - Search Results

1

Frequency-dependent properties of a fluid jet stimulus: calibration, modeling, and application to cochlear hair cell bundles.

Dinklo T, Meulenberg CJ, van Netten SM. Dinklo T, et al. J Assoc Res Otolaryngol. 2007 Jun;8(2):167-82. doi: 10.1007/s10162-007-0080-0. Epub 2007 Mar 27. J Assoc Res Otolaryngol. 2007. PMID: 17387553 Free PMC article.

2

Channel gating forces govern accuracy of mechano-electrical transduction in hair cells.

van Netten SM, Dinklo T, Marcotti W, Kros CJ. van Netten SM, et al. Among authors: dinklo t. Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15510-5. doi: 10.1073/pnas.2632626100. Epub 2003 Dec 10. Proc Natl Acad Sci U S A. 2003. PMID: 14668434 Free PMC article.

3

Unexpected neurotoxicity in chronic toxicity studies with a HBV viral expression inhibitor.

Bopst M, Dinklo T, Funk J, Greiter-Wilke A, Lenz B, Kustermann S, Jiang T, Xie J. Bopst M, et al. Among authors: dinklo t. Regul Toxicol Pharmacol. 2023 Jun;141:105407. doi: 10.1016/j.yrtph.2023.105407. Epub 2023 May 2. Regul Toxicol Pharmacol. 2023. PMID: 37141985

4

Reprint of: Nonclinical species sensitivity to convulsions: An IQ DruSafe consortium working group initiative.

DaSilva JK, Breidenbach L, Deats T, Li D, Treinen K, Dinklo T, Kervyn S, Teuns G, Traebert M, Hempel K. DaSilva JK, et al. Among authors: dinklo t. J Pharmacol Toxicol Methods. 2020 Sep;105:106919. doi: 10.1016/j.vascn.2020.106919. Epub 2020 Sep 30. J Pharmacol Toxicol Methods. 2020. PMID: 33011055

5

Nonclinical species sensitivity to convulsions: An IQ DruSafe consortium working group initiative.

DaSilva JK, Breidenbach L, Deats T, Li D, Treinen K, Dinklo T, Kervyn S, Teuns G, Traebert M, Hempel K. DaSilva JK, et al. Among authors: dinklo t. J Pharmacol Toxicol Methods. 2020 May-Jun;103:106683. doi: 10.1016/j.vascn.2020.106683. Epub 2020 Feb 24. J Pharmacol Toxicol Methods. 2020. PMID: 32105757

6

A Framework Proposal to Follow-Up on Preclinical Convulsive Signals of a New Molecular Entity in First-in-Human Studies Using Electroencephalographic Monitoring.

Abt M, Dinklo T, Rothfuss A, Husar E, Dannecker R, Kallivroussis K, Peck R, Doessegger L, Wandel C. Abt M, et al. Among authors: dinklo t. Clin Pharmacol Ther. 2019 Nov;106(5):968-980. doi: 10.1002/cpt.1455. Epub 2019 May 31. Clin Pharmacol Ther. 2019. PMID: 30993670 Free PMC article. Review.

7

Variability of non-clinical behavioral CNS safety assessment: An intercompany comparison.

Himmel HM; Irwin/FOB Consortium Members; Delaunois A, Deurinck M, Dinklo T, Eriksson Faelker TM, Habermann C, Heers C, Hempel K, Lorenz H, Rosch A, Schauerte H, Teuns G, Traebert M, van Amsterdam C, van der Linde H. Himmel HM, et al. Among authors: dinklo t. J Pharmacol Toxicol Methods. 2019 Sep-Oct;99:106571. doi: 10.1016/j.vascn.2019.03.002. Epub 2019 Mar 27. J Pharmacol Toxicol Methods. 2019. PMID: 30928509

8

Characterization of 2-[[4-fluoro-3-(trifluoromethyl)phenyl]amino]-4-(4-pyridinyl)-5-thiazolemethanol (JNJ-1930942), a novel positive allosteric modulator of the {alpha}7 nicotinic acetylcholine receptor.

Dinklo T, Shaban H, Thuring JW, Lavreysen H, Stevens KE, Zheng L, Mackie C, Grantham C, Vandenberk I, Meulders G, Peeters L, Verachtert H, De Prins E, Lesage AS. Dinklo T, et al. J Pharmacol Exp Ther. 2011 Feb;336(2):560-74. doi: 10.1124/jpet.110.173245. Epub 2010 Nov 17. J Pharmacol Exp Ther. 2011. PMID: 21084390

9

Desensitization characteristics of the human alpha7nAChR/5HT3A chimera receptor.

Dinklo T, Lesage AS, Grantham CG. Dinklo T, et al. J Mol Neurosci. 2006;30(1-2):109-10. doi: 10.1385/JMN:30:1:109. J Mol Neurosci. 2006. PMID: 17192651

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page